Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences. [electronic resource]
Producer: 20190624Description: 534-539 p. digitalISSN:- 1473-5687
- 2-Naphthylamine
- Adult
- Aged
- Aged, 80 and over
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Hepacivirus -- isolation & purification
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Renal Insufficiency, Chronic -- complications
- Retrospective Studies
- Ritonavir -- administration & dosage
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Uracil -- administration & dosage
- Valine
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.